TY - JOUR
T1 - Coeliac disease
T2 - what can we learn from prospective studies about disease risk?
AU - Stahl, Marisa
AU - Koletzko, Sibylle
AU - Andrén Aronsson, Carin
AU - Lindfors, Katri
AU - Liu, Edwin
AU - Agardh, Daniel
AU - TEDDY Study Group
AU - Oikarinen, Sami
AU - Lönnrot, Maria
AU - Koreasalo, Mirva
AU - Kurppa, Kalle
AU - Hakola, Leena
AU - Ahonen, Suvi
AU - Åkerlund, Mari
AU - Mattila, Markus
AU - Virtanen, Suvi
AU - Hyöty, Heikki
N1 - Copyright © 2023 Elsevier Ltd. All rights reserved.
PY - 2024
Y1 - 2024
N2 - Paediatric prospective studies of coeliac disease with longitudinal collection of biological samples and clinical data offer a unique perspective on disease risk. This Review highlights the information now available from international paediatric prospective studies on genetic and environmental risk factors for coeliac disease. In addition, recent omics studies have made it possible to study complex interactions between genetic and environmental factors and thereby further our insight into the causes of the disease. In the future, paediatric prospective studies will be able to provide more detailed risk prediction models combining genes, the environment, and biological corroboration from multiomics. Such studies could also contribute to biomarker development and an improved understanding of disease pathogenesis.
AB - Paediatric prospective studies of coeliac disease with longitudinal collection of biological samples and clinical data offer a unique perspective on disease risk. This Review highlights the information now available from international paediatric prospective studies on genetic and environmental risk factors for coeliac disease. In addition, recent omics studies have made it possible to study complex interactions between genetic and environmental factors and thereby further our insight into the causes of the disease. In the future, paediatric prospective studies will be able to provide more detailed risk prediction models combining genes, the environment, and biological corroboration from multiomics. Such studies could also contribute to biomarker development and an improved understanding of disease pathogenesis.
U2 - 10.1016/S2352-4642(23)00232-8
DO - 10.1016/S2352-4642(23)00232-8
M3 - Review Article
C2 - 37972632
SN - 2352-4642
VL - 8
SP - 63
EP - 74
JO - The Lancet. Child and adolescent health
JF - The Lancet. Child and adolescent health
IS - 1
ER -